Adverum is advancing a robust pipeline of gene therapy product candidates. Its lead candidate, ADVM (also known as Ixo-vec), is an intravitreal (IVT). Get the latest Adverum Biotechnologies Inc (ADVM) real-time quote, historical performance, charts, and other financial information to help you make more. Adverum Biotechnologies (NASDAQ:ADVM) Stock Quotes, Forecast and News Summary ; Close, $ ; Volume / Avg. K / K ; Day Range, $ - $ ; 52 Wk. Adverum Biotechnologies Inc. ; Volume, K ; Market Value, $M ; Shares Outstanding, M ; EPS (TTM), -$ ; P/E Ratio (TTM), N/A. View Adverum Biotechnologies, Inc. ADVM stock quote prices, financial information, real-time forecasts, and company news from CNN.
ADVM stock results show that Adverum Biotechnologies beat analyst estimates for earnings per share the second quarter of ADVM Stock Earnings: Adverum. At Adverum, we are driven to establish ocular gene therapy as a new standard of care for debilitating retinal diseases. ADVM | Complete Adverum Biotechnologies Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. News for Adverum Biotechnologies Stock (ADVM) · All You Need to Know About Adverum Biotechnologies (ADVM) Rating Upgrade to Buy · Implied Volatility Surging for. Stay up-to-date on Adverum Biotechnologies, Inc. Common Stock (ADVM) news with the latest updates, breaking headlines, news articles, and more from around. Based on 7 Wall Street analysts offering 12 month price targets for Adverum Biotechnologies in the last 3 months. The average price target is $ with a high. Get Adverum Biotechnologies Inc (ADVM:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Adverum Biotechnologies, Inc NASDAQ: ADVM is a clinical-stage gene therapy focused on unmet medical needs in ocular and rare diseases. Adverum develops gene. Truist Financial reaffirmed a "buy" rating and issued a $ price objective on shares of Adverum Biotechnologies in a research report on Wednesday. May Real time Adverum Biotechnologies (ADVM) stock price quote, stock graph, news & analysis. View live Adverum Biotechnologies, Inc. chart to track its stock's price action. Find market predictions, ADVM financials and market news.
Adverum Biotechnologies is a clinical-stage company that aims to establish gene therapy as a new standard of care for a number of highly prevalent ocular. News & Press Releases · Adverum Biotechnologies Reports Second Quarter Financial Results and Provides Program and Corporate Highlights · Adverum. Adverum Biotechnologies, Inc. is a clinical-stage biotechnology company that engages in the development of novel gene therapies to treat patients with. View Adverum Biotechnologies (ADVM) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. NASDAQ: ADVM ; Price. $ Volume. , ; Change. + % Change. +% ; Today's Open. $ Previous Close. $ Rewards · Risk Analysis · Adverum Biotechnologies, Inc. · Price History & Performance · Recent News & Updates · Adverum Biotechnologies Announces Fda Regenerative. Get the latest Adverum Biotechnologies, Inc. (ADVM) stock news and headlines to help you in your trading and investing decisions. Discover real-time Adverum Biotechnologies, Inc. Common Stock (ADVM) stock prices, quotes, historical data, news, and Insights for informed trading and. Key Stock Data · P/E Ratio (TTM). N/A · EPS (TTM). $ · Market Cap. $ M · Shares Outstanding. M · Public Float. M · Yield. ADVM is not.
Track Adverum Biotechnologies Inc (ADVM) Stock Price, Quote, latest community messages, chart, news and other stock related information. Press Releases · August 12, Adverum Biotechnologies Reports Second Quarter Financial Results and Provides Program and Corporate Highlights · August 2. On Wednesday 08/07/ the closing price of the Adverum Biotechnologies Inc Registered Shs share was $ on BTT. Compared to the opening price on Wednesday. Adverum Biotechnologies Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker ADVM. The last closing price for Adverum. On average, Wall Street analysts predict that Adverum Biotechnologies's share price could reach $ by Aug 14, The average Adverum Biotechnologies.
Adverum Biotechnologies Inc Stock News from GuruFocus · Jun 18, Adverum Biotechnologies to Participate in TD Cowen's Genetic Medicines & RNA Summit · Jun Adverum Biotechnologies Inc. News · JIM CRAMER. Jan 16, PM EST ; Adverum Biotechnologies Inc. News from TheStreet Pro · Trade Ideas. Aug 7, AM. Latest news: Adverum Biotechnologies, Inc. · Truist Adjusts Price Target on Adverum Biotechnologies to $40 From $60, Maintains Buy Rating · RBC Adjusts Price. Get Adverum Biotechnologies Inc (doz-zabudova.ru) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. Adverum Biotechnologies ; Profitability Metrics. Gross Margin (ttm). N/A ; Revenue and Earnings Metrics. Revenue (ttm). $0 ; Cash and Debt Metrics. Total Cash. Adverum Biotechnologies Inc News & Analysis · Mizuho cuts Adverum Biotechnologies target to $20 from $22 · Avalanche Biotec receives Investment Bank Analyst.